CK Life Sciences International (Holdings) Inc. has entered into agreements to dispose of 100% of the issued and outstanding membership interests in a target company. As part of the transaction, consideration shares-comprising both common and preferred stock-will be issued to the seller. Upon conversion of all related preferred shares, the seller is expected to hold approximately 90.7% of the outstanding shares of the purchaser's common stock.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CK Life Sciences International (Holdings) Inc. published the original content used to generate this news brief on October 08, 2025, and is solely responsible for the information contained therein.